Sugawara Teruo, Sakuragi Noriaki, Minakami Hisanori
Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
J Endocrinol. 2006 Oct;191(1):327-37. doi: 10.1677/joe.1.06601.
Steroidogenic acute regulatory (StAR) protein plays a critical role in steroid hormone synthesis. Tropic hormones induce human StAR gene expression by a cAMP-dependent pathway. Steroidogenic factor-1/adrenal-4-binding protein (SF-1/Ad4BP) plays an important role in the expression of human StAR gene. We investigated the mechanism of cAMP responsiveness in human StAR gene expression in NCI-H295R cells. The StAR promoter activity and protein levels in cells subjected to various treatments were examined. Anti-SF-1/Ad4BP IgG transfection treatment resulted in decreases in the basal StAR promoter activity and StAR protein levels, but did not affect cAMP-stimulated promoter activity and protein levels. The basal and cAMP-stimulated StAR promoter activity levels were reduced in SF-1/Ad4BP mutant (G35E)-transfected cells, but the cAMP induction of StAR promoter activity in response to 1 mM 8-Br-cAMP was not inhibited when G35E SF-1/Ad4BP mutant expression vectors were co-transfected with cAMP-response element-binding (CREB) expression vectors. Although the basal StAR mRNA expression and protein levels were decreased by SF-1/Ad4BP-siRNA treatment, the cAMP-stimulated StAR mRNA expression and protein levels did not change. The basal StAR promoter activity level was not decreased by cAMP-response element modulator (CREM)-siRNA treatment, but the cAMP-stimulated StAR promoter activity level, the magnitude of cAMP induction of StAR promoter, and the cAMP-stimulated StAR protein level were decreased. The cAMP induction of StAR promoter activity in cells was inhibited when S117ACREM mutant expressionvectors were transfected. We conclude that inhibition of the function of SF-1/Ad4BP does not reduce the cAMP induction of StAR promoter activity and protein level. CREM is needed to confer cAMP responsiveness in human StAR protein expression.
类固醇生成急性调节(StAR)蛋白在类固醇激素合成中起关键作用。促性腺激素通过cAMP依赖性途径诱导人StAR基因表达。类固醇生成因子-1/肾上腺4结合蛋白(SF-1/Ad4BP)在人StAR基因表达中起重要作用。我们研究了NCI-H295R细胞中人StAR基因表达中cAMP反应性的机制。检测了经过各种处理的细胞中StAR启动子活性和蛋白水平。抗SF-1/Ad4BP IgG转染处理导致基础StAR启动子活性和StAR蛋白水平降低,但不影响cAMP刺激的启动子活性和蛋白水平。在转染了SF-1/Ad4BP突变体(G35E)的细胞中,基础和cAMP刺激的StAR启动子活性水平降低,但当G35E SF-1/Ad4BP突变体表达载体与cAMP反应元件结合(CREB)表达载体共转染时,对1 mM 8-溴-cAMP的cAMP诱导的StAR启动子活性未被抑制。虽然SF-1/Ad4BP-siRNA处理降低了基础StAR mRNA表达和蛋白水平,但cAMP刺激的StAR mRNA表达和蛋白水平未改变。cAMP反应元件调节剂(CREM)-siRNA处理未降低基础StAR启动子活性水平,但cAMP刺激的StAR启动子活性水平、StAR启动子的cAMP诱导幅度以及cAMP刺激的StAR蛋白水平降低。当转染S117ACREM突变体表达载体时,细胞中StAR启动子活性的cAMP诱导受到抑制。我们得出结论,抑制SF-1/Ad4BP的功能不会降低StAR启动子活性和蛋白水平的cAMP诱导。在人StAR蛋白表达中赋予cAMP反应性需要CREM。